ロード中...
A Gene Expression Signature for Predicting Response to Neoadjuvant Chemoradiotherapy in Pancreatic Ductal Adenocarcinoma
In patients with pancreatic ductal adenocarcinoma (PDAC), optimal treatment selection, including multimodality regimens such as neoadjuvant chemoradiotherapy (NACRT) can be clinically transformative. Unfortunately, currently no predictive biomarkers are available that can guide the use of NACRT in P...
保存先:
| 出版年: | Int J Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8221275/ https://ncbi.nlm.nih.gov/pubmed/32895958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33284 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|